User profiles for J Stebbing

Justin Stebbing

Imperial College
Verified email at imperial.ac.uk
Cited by 33157

[HTML][HTML] PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

…, E Toska, MS Davids, JR Brown, P Diana, J Stebbing… - Molecular cancer, 2023 - Springer
The PI3K/AKT/mTOR (PAM) signaling pathway is a highly conserved signal transduction
network in eukaryotic cells that promotes cell survival, cell growth, and cell cycle progression. …

Clinical characteristics and outcomes of COVID-19–infected cancer patients: a systematic review and meta-analysis

…, H Chen, V Velcheti, J Stebbing… - JNCI: Journal of the …, 2021 - academic.oup.com
Background Previous studies have indicated coronavirus disease 2019 (COVID-19) patients
with cancer have a high fatality rate. Methods We conducted a systematic review of studies …

Circulating tumor cells in breast cancer patients treated by neoadjuvant chemotherapy: a meta-analysis

…, L Muinelo-Romay, J Stebbing… - JNCI: Journal of the …, 2018 - academic.oup.com
Background We conducted a meta-analysis in nonmetastatic breast cancer patients treated
by neoadjuvant chemotherapy (NCT) to assess the clinical validity of circulating tumor cell (…

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

…, A Phelan, M Rawling, E Savory, J Stebbing - The lancet, 2020 - thelancet.com
Given the scale and rapid spread of the 2019 novel coronavirus (2019-nCoV) acute respiratory
disease, there is an immediate need for medicines that can help before a vaccine can be …

[HTML][HTML] COVID-19: combining antiviral and anti-inflammatory treatments

J Stebbing, A Phelan, I Griffin, C Tucker… - The Lancet Infectious …, 2020 - thelancet.com
The Lancet, 3 we described how BenevolentAI’s proprietary artificial intelligence (AI)-derived
knowledge graph, 4 queried by a suite of algorithms, enabled identification of a target and …

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

…, D Generali, JA Garcia-Saenz, J Stebbing… - The lancet …, 2014 - thelancet.com
Background We aimed to assess the clinical validity of circulating tumour cell (CTC) quantification
for prognostication of patients with metastatic breast cancer by undertaking a pooled …

Mechanism of baricitinib supports artificial intelligence‐predicted testing in COVID‐19 patients

J Stebbing, V Krishnan, S de Bono… - EMBO molecular …, 2020 - embopress.org
Baricitinib is an oral Janus kinase ( JAK )1/ JAK 2 inhibitor approved for the treatment of
rheumatoid arthritis ( RA ) that was independently predicted, using artificial intelligence ( AI ) …

[PDF][PDF] Highly active antiretroviral therapy and the incidence of non–AIDS-defining cancers in people with HIV infection

T Powles, D Robinson, J Stebbing, J Shamash… - Journal of Clinical …, 2009 - Citeseer
J Natl Cancer Inst 92:1823-1830, 2000 5. Herida M, Mary-Krause M, Kaphan R, et al:
Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral …

Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence

…, S Ahmed, S Ali, S Cleator, L Kenny, J Stebbing… - Clinical Cancer …, 2019 - AACR
Purpose: Up to 30% of patients with breast cancer relapse after primary treatment. There
are no sensitive and reliable tests to monitor these patients and detect distant metastases …

The estrogen receptor-α-induced microRNA signature regulates itself and its transcriptional response

…, J Waxman, GJ Hannon, J Stebbing - Proceedings of the …, 2009 - National Acad Sciences
Following estrogenic activation, the estrogen receptor-α (ERα) directly regulates the
transcription of target genes via DNA binding. MicroRNAs (miRNAs) modulated by ERα have the …